[go: up one dir, main page]

RU2001132735A - SOLID MEDICINAL FORM BASED ON CARVEDILOL - Google Patents

SOLID MEDICINAL FORM BASED ON CARVEDILOL

Info

Publication number
RU2001132735A
RU2001132735A RU2001132735/15A RU2001132735A RU2001132735A RU 2001132735 A RU2001132735 A RU 2001132735A RU 2001132735/15 A RU2001132735/15 A RU 2001132735/15A RU 2001132735 A RU2001132735 A RU 2001132735A RU 2001132735 A RU2001132735 A RU 2001132735A
Authority
RU
Russia
Prior art keywords
dosage form
solid dosage
carvedilol
form according
saccharide
Prior art date
Application number
RU2001132735/15A
Other languages
Russian (ru)
Other versions
RU2214243C2 (en
Original Assignee
Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин"
Filing date
Publication date
Application filed by Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" filed Critical Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин"
Priority to RU2001132735A priority Critical patent/RU2214243C2/en
Priority claimed from RU2001132735A external-priority patent/RU2214243C2/en
Application granted granted Critical
Publication of RU2214243C2 publication Critical patent/RU2214243C2/en
Publication of RU2001132735A publication Critical patent/RU2001132735A/en

Links

Claims (6)

1. Твердая лекарственная форма, содержащая в качестве действующего вещества карведилол и в качестве фармацевтически приемлемых вспомогательных веществ сахарид, крахмал, стеариновую кислоту и/или ее соль при следующем соотношении ингредиентов, мас.%:1. A solid dosage form containing carvedilol as active ingredient and pharmaceutically acceptable excipients, saccharide, starch, stearic acid and / or its salt in the following ratio of ingredients, wt.%: Карведилол 1,0-25,0Carvedilol 1.0-25.0 Крахмал 0,1-3,5Starch 0.1-3.5 Сахарид 70,0-96,9Saccharide 70.0-96.9 Кислота стеариноваяStearic acid и/или ее соль 0,6-1,5and / or its salt 0.6-1.5 2. Твердая лекарственная форма по п.1, отличающаяся тем, что содержит в качестве соли стеариновой кислоты стеарат кальция или магния.2. The solid dosage form according to claim 1, characterized in that it contains calcium or magnesium stearate as the salt of stearic acid. 3. Твердая лекарственная форма по п.1, отличающаяся тем, что содержит в качестве сахарида маннит или лактозу.3. The solid dosage form according to claim 1, characterized in that it contains mannitol or lactose as a saccharide. 4. Твердая лекарственная форма по п.1, отличающаяся тем, что содержит в качестве сахарида модифицированную лактозу.4. The solid dosage form according to claim 1, characterized in that it contains modified lactose as a saccharide. 5. Твердая лекарственная форма по пп.1-4, отличающаяся тем, что содержит в качестве крахмала модифицированный крахмал.5. The solid dosage form according to claims 1 to 4, characterized in that it contains modified starch as starch. 6. Твердая лекарственная форма по любому из пп.1-5, отличающаяся тем, что выполнена в форме таблетки.6. A solid dosage form according to any one of claims 1 to 5, characterized in that it is made in the form of a tablet.
RU2001132735A 2001-12-05 2001-12-05 Carvedilol-base solid medicinal form RU2214243C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2001132735A RU2214243C2 (en) 2001-12-05 2001-12-05 Carvedilol-base solid medicinal form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2001132735A RU2214243C2 (en) 2001-12-05 2001-12-05 Carvedilol-base solid medicinal form

Publications (2)

Publication Number Publication Date
RU2214243C2 RU2214243C2 (en) 2003-10-20
RU2001132735A true RU2001132735A (en) 2004-04-20

Family

ID=31988543

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001132735A RU2214243C2 (en) 2001-12-05 2001-12-05 Carvedilol-base solid medicinal form

Country Status (1)

Country Link
RU (1) RU2214243C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261094C1 (en) * 2004-04-06 2005-09-27 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Solid medicinal formulation for treatment of arterial hypertension and method for its preparing
RU2353352C1 (en) * 2007-11-23 2009-04-27 Закрытое Акционерное Общество "БИОКОМ" Antiinflammatory, analgesic, antipyretic solid formulation and preparation method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229085C2 (en) * 1992-09-01 1996-07-11 Boehringer Mannheim Gmbh Elongated, divisible tablet

Similar Documents

Publication Publication Date Title
CA2311734C (en) Flash-melt oral dosage formulation
NO2025027I1 (en) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - extended.
US4866046A (en) Low-dosage sublingual aspirin
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
CA2427815A1 (en) Controlled release hydrocodone formulations
RU96116411A (en) QUICKLY DISPERSABLE READY-FORMED DRUG FORM TRAMADOL OR TRAMADOL SALT
RU96118271A (en) COMPOSITIONS CONTAINING FINE-CREATED NEBIVOL
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
EA200400471A1 (en) ORAL DOSED FORM PROPIVERINA
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
WO1998009597A3 (en) Cushioning beads and tablet comprising the same capable of forming a suspension
RU2226394C2 (en) Oral medicinal formulations with reproducible indices of active substance gatifloxacine releasing or its pharmaceutically acceptable salts or hydrates
IS7006A (en) Dihydrogen 3-piperidinopropiophenone and medicinal products containing said compounds
EP0749308A1 (en) Film coated tablet of paracetamol and domperidone
RU2003100507A (en) PHARMACEUTICAL COMPOSITIONS
RU2000130202A (en) ORAL DOSAGE FORMS WITH REPRODUCABLE INDICATORS OF RELEASE OF THE ACTIVE SUBSTANCE OF HATIFLOXACIN OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR HYDRATES
KR900004326A (en) Dispersible tablets of dihydrogergotoxin and its acid addition salt
JP2006232675A (en) Combined type solid preparation for oral dissolution
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
HUP0203148A2 (en) Orally distintegrating composition comprising mirtazapine
RU2001132735A (en) SOLID MEDICINAL FORM BASED ON CARVEDILOL
CA2120001A1 (en) Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
BE2016C017I2 (en)
RU2003132049A (en) PHARMACEUTICAL COMPOSITION Possessing Cerebrovasodilating and Nootropic Activity
RU97105462A (en) SOLID MEDICINAL FORM BASED ON ENALAPRIL